Skip to content

EBITDA at other companies

ESAB logo
ESABESAB
$114.35M-10.2%
Vericel logo
VericelVCEL
-$4.8M+52.5%
CONMED logo
CONMEDCNMD
$38.29M+32.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
Stryker logo
StrykerSYK
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.27B-26.3%
Enterprise value$2.59B-16.0%
P/S0.6×-0.2×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Calculated from Enovis’s reported figures.

$6.5Mebit+
$73.4MDepreciation Depletion & Amortization
=$79.89M

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's EBITDA?
Enovis (ENOV) reported EBITDA of $79.89M in Q1 2026.
How has Enovis's EBITDA changed year-over-year?
Enovis's EBITDA increased by 223.9% year-over-year, from $24.67M to $79.89M.
What is the long-term trend for Enovis's EBITDA?
Over 4 years (2021 to 2025), Enovis's EBITDA has grown at a 31.3% compound annual growth rate (CAGR), from $280.01M to -$833.27M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.